Chronic Kidney Disease Patients clinical trials

Explore recruiting chronic kidney disease patients clinical trials.

Recruiting chronic kidney disease patients studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Kidney Disease Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of dapagliflozin on vascular function in chronic kidney disease patients - (DAPA-VASC)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Phase IIa Trial Exploring the Safety, Tolerability, and Efficacy of the T Cell Engager OM336 for Desensitization of Kidney Transplant Candidates

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

TRANSPGx: A multicentre, controlled, randomised and single-blind, adaptive phase IV protocol to evaluate effectiveness and cost-effectiveness of pre-emptive genotyping strategy to optimise tacrolimus dosage in a pretransplant chronic kidney disease population cohort

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Chronic Kidney Disease Patients trials by city

Chronic Kidney Disease Patients clinical trials

Recruiting chronic kidney disease patients studies right now

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients

First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients

Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients

The Effect of Intradialytic Eye Exercise in Hemodialysis Patients

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic Kidney Disease in Patients With Diabetes.

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure

Also recruiting in Europe

Impact of dapagliflozin on vascular function in chronic kidney disease patients - (DAPA-VASC)

An Open-Label Phase IIa Trial Exploring the Safety, Tolerability, and Efficacy of the T Cell Engager OM336 for Desensitization of Kidney Transplant Candidates

TRANSPGx: A multicentre, controlled, randomised and single-blind, adaptive phase IV protocol to evaluate effectiveness and cost-effectiveness of pre-emptive genotyping strategy to optimise tacrolimus dosage in a pretransplant chronic kidney disease population cohort

Chronic Kidney Disease Patients trials by city

Other conditions